Home           Contact us           FAQs           
   Journal Page   |   Aims & Scope   |   Author Guideline   |   Editorial Board   |   Search
2011 (Vol. 2, Issue: 3)
Article Information:

Simultaneous Treatment of Cancer Cells Lines with the Anticancer Drug Cisplatin and the Antioxidant Fucoxanthin

Takeshi Mise and Takeshi Yasumoto
Corresponding Author:  Takeshi Mise 

Key words:  Anticancer agent, carotenoid, fucoxanthinol, , , ,
Vol. 2 , (3): 127-131
Submitted Accepted Published
2011 April, 10 2011 May, 13 2011 August, 05

The anti-oxidative properties and the other health benefits of fucoxanthin (Fx) make it a good candidate for a health food supplement. However, the use of antioxidant supplements in patients undergoing chemotherapy has been widely debated because of concerns that the antioxidants may interfere with the mechanisms of the anticancer drugs. To investigate this concern, we studied the effect of Fx on the anticancer drug cisplatin. Fucoxanthinol (Fxol), which is a deacetylated product produced during intestinal absorption, and other antioxidants (fucoxanthin acetate, astaxanthin, and "-tocopherol) were also included in the experiments. Both Fx and Fxol suppressed the proliferation of cultured cancer cells (Caco-2, Hep G2, and Neuro2a) in a dose-dependent manner, whereas the other antioxidants showed no evident effect on their growth. Moreover, when added to a medium containing cisplatin, none of the studied antioxidants mitigated the inhibitory growth effects of cisplatin. Our results suggested that intake of Fx may help to prevent cancer and that it may not interfere with the mechanisms of anticancer drugs during chemotherapy. However, further studies, using animal models in particular, are required to elucidate these interactions.
Abstract PDF HTML
  Cite this Reference:
Takeshi Mise and Takeshi Yasumoto, 2011. Simultaneous Treatment of Cancer Cells Lines with the Anticancer Drug Cisplatin and the Antioxidant Fucoxanthin.  British Journal of Pharmacology and Toxicology, 2(3): 127-131.
    Advertise with us
ISSN (Online):  2044-2467
ISSN (Print):   2044-2459
Submit Manuscript
   Current Information
   Sales & Services
   Contact Information
  Executive Managing Editor
  Email: admin@maxwellsci.com
  Publishing Editor
  Email: support@maxwellsci.com
  Account Manager
  Email: faisalm@maxwellsci.com
  Journal Editor
  Email: admin@maxwellsci.com
  Press Department
  Email: press@maxwellsci.com
Home  |  Contact us  |  About us  |  Privacy Policy
Copyright © 2009. MAXWELL Science Publication, a division of MAXWELLl Scientific Organization. All rights reserved